Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Issue of Equity & Update to Dividend Timetable

3 Jun 2024 07:00

RNS Number : 7201Q
Spectra Systems Corporation
03 June 2024
 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

For immediate release

03 June 2024

 

Spectra Systems Corporation

("Spectra" or the "Group")

 

Issue of second tranche of consideration shares for Cartor Holdings Limited ("Cartor") and update to dividend timetable

Spectra Systems Corporation (AIM: SPSY.L), a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, announces that it will issue 403,812 new shares of common stock of $0.01 each in the Company ("Shares") to the selling shareholders of Cartor, at an issue price of £2.476398 per share. This issue of shares settles the final element of the initial £3.0 million of equity consideration, referred to in the announcement dated 4 December 2023, £1.0 million of was deferred at completion of the acquisition, pending resolution of a pension scheme matter within Cartor.

Accordingly, the Company has applied for 403,812 Shares to be admitted to trading on AIM, which is expected to take place on or around 5 June 2024 ("Admission").

In addition, restrictive legends have been removed from a further 70,116 shares of common stock of the Company. As a result, these shares have transferred from the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC) into the unrestricted stock line ISIN number US84756T1060 (AIM:SPSY).

Following Admission, the Company's issued share capital will comprise:

· 779,695 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

· 47,440,282 shares in the unrestricted stock line ISIN number US84756T1060 (AIM:SPSY).

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission will be 48,219,977 shares with voting rights attached (one vote per share). There are no shares held in treasury, therefore this figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Spectra under the DTRs.

Dividend Timetable

The Company also announces an update to its dividend timetable first announced on 27 March 2024. The Company intends to pay an annual dividend of US$0.116 per share on or about June 28, 2024 to shareholders of record as of June 14, 2024.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Joint Broker)

Chris Fielding/ James Bavister (Corporate Finance)

Fraser Marshall (Corporate Broking)

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

Tel: +44 (0)20 3328 5665

 

Important Notices:

The person responsible for arranging the release of this announcement on behalf of the Company is Dr. Nabil Lawandy, Chief Executive Officer of Spectra.

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This announcement contains certain forward-looking statements. No forward-looking statement is a guarantee of future performance and actual results or performance or other financial condition could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact they do not relate only to historical or current facts. They may contain words such as "may", "will", "seek", "continue", "aim", "anticipate", "target", "projected", "expect", "estimate", "intend", "plan", "goal", "believe", "achieve" or other words with similar meaning. By their nature forward looking statements involve risk and uncertainty because they relate to future events and circumstances. A number of these influences and factors are outside of the Group's control. As a result, actual results may differ materially from the plans, goals and expectations contained in this announcement. No statement in this announcement is intended to be, nor may it be construed as, a profit forecast or be relied upon as a guide to future performance. Any forward-looking statements made in this announcement speak only as of the date they are made. Except as required by applicable law or regulation, Spectra expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUASVRSRUVOAR
Date   Source Headline
22nd May 20262:45 pmRNSAdditional Sensor order
16th Apr 20267:00 amRNSExercise of Options and Total Voting Rights
8th Apr 20267:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20267:00 amRNSAudited results for year ended 31 December 2025
5th Feb 20267:00 amRNSExecuted Contract with HMRC for Vaping Duty Stamps
16th Jan 20267:00 amRNSSuccessful Bid for HMRC Vaping Duty Stamps Scheme
8th Dec 20257:00 amRNSTransaction in Own Shares & TVR
26th Nov 20257:01 amRNSTransaction in Own Shares & TVR
26th Nov 20257:00 amRNSMaintenance contract for new sensors
25th Nov 20257:00 amRNSShare Buyback Programme
16th Oct 20257:00 amRNSAppointment of Finance Director
29th Sep 20257:00 amRNSInterim Results for Six Months Ended 30 June 2025
9th Sep 20252:59 pmRNSNotice of Interim Results
27th Jun 20257:00 amRNSExercise of Options
24th Jun 20254:48 pmRNSAnnual General Meeting Lack of Quorum
11th Jun 20257:00 amRNSNotice of AGM
27th May 20255:33 pmRNSAppointment of Finance Director
9th Apr 20254:55 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSExercise of Options & Removal of Reg S
31st Mar 20257:00 amRNSAudited results for year ended 31 December 2024
9th Jan 20257:00 amRNSExercise of Options
18th Dec 20243:58 pmRNSExercise of Options
18th Dec 20247:00 amRNS$9.4M downpayment on sensor manufacturing contract
21st Oct 20244:00 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
20th Aug 20244:35 pmRNSRemoval of Reg S restrictions from common stock
30th Jul 20247:00 amRNSAnnual General Meeting Lack of Quorum
18th Jul 20244:52 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNew $37.9 million sensor manufacturing contract
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
28th Jun 20241:46 pmRNSReplacement: Posting of Annual Report
28th Jun 202410:14 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20247:00 amRNSIssue of Equity & Update to Dividend Timetable
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.